Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer
- PMID: 27010533
- DOI: 10.3109/09553002.2016.1162921
Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer
Abstract
Purpose: To assess whether anaerobic metabolism, proliferation activity and stem cell content are linked with radioresistance in bladder cancer.
Materials and methods: Tissue sections from 66 patients with invasive transitional cell bladder cancer treated with hypofractionated accelerated radiotherapy, was immunohistochemically analyzed for the Hypoxia-Inducible Factor 1α (HIF1α) and the anaerobic glycolysis enzyme lactate dehydrogenase 5 (LDH5). Proliferation index (Ki-67) and stem-cell marker (cluster of differentiation CD44, aldehyde dehydrogenase ALDH1) expression was also examined.
Results: Both HIF1α and LDH5 expression were linked with high CD44 stem cell population (p = 0.001 and 0.05, respectively), while high Ki-67 proliferation index was linked with nuclear LDH5 expression (p = 0.03) and high histological grade (p = 0.02). A strong significant association of HIF1α (p = 0.0009) and of LDH5 (p < 0.0001) with poor local relapse free survival (LRFS) was noted, which was also confirmed in multivariate analysis. A significant association with overall survival was also noted. Silencing of lactate dehydrogenase LDHA gene in the human RT112 bladder cancer cell line, or exposure to oxamate (LDH activity inhibitor), resulted in strong radio-sensitization.
Conclusions: HIF1α and LDH5 are markers of poor outcome in patients with bladder cancer treated with radiotherapy. Blockage of anaerobic metabolism may prove of importance in clinical radiotherapy.
Keywords: CD44; HIF1α; LDH; bladder cancer; proliferation index; radiotherapy.
Similar articles
-
Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.Breast Cancer Res Treat. 2022 Jul;194(1):13-23. doi: 10.1007/s10549-022-06609-0. Epub 2022 Apr 28. Breast Cancer Res Treat. 2022. PMID: 35482128
-
Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy.Int J Radiat Biol. 2019 Apr;95(4):408-426. doi: 10.1080/09553002.2018.1490041. Epub 2018 Oct 16. Int J Radiat Biol. 2019. PMID: 29913092 Review.
-
[Prognostic importance of lactate dehydrogenase (LDH) in oncology].Orv Hetil. 2017 Dec;158(50):1977-1988. doi: 10.1556/650.2017.30890. Orv Hetil. 2017. PMID: 29226713 Review. Hungarian.
-
Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy.Oncology. 2009;77(5):285-92. doi: 10.1159/000259260. Epub 2009 Nov 16. Oncology. 2009. PMID: 19923867
-
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.Clin Exp Metastasis. 2005;22(1):25-30. doi: 10.1007/s10585-005-2343-7. Clin Exp Metastasis. 2005. PMID: 16132575
Cited by
-
Therapeutic implications of cancer stem cells in prostate cancer.Cancer Biol Med. 2023 Jun 5;20(6):401-20. doi: 10.20892/j.issn.2095-3941.2022.0714. Cancer Biol Med. 2023. PMID: 37282627 Free PMC article. Review.
-
HIF1α-dependent and independent pathways regulate the expression of PD-L1 in prostate cancer.Med Oncol. 2023 Apr 17;40(5):151. doi: 10.1007/s12032-023-02017-6. Med Oncol. 2023. PMID: 37067635 Free PMC article.
-
Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy.Int J Biol Sci. 2023 Jan 1;19(3):811-828. doi: 10.7150/ijbs.79928. eCollection 2023. Int J Biol Sci. 2023. PMID: 36778122 Free PMC article. Review.
-
LDH-A-Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses.Cancers (Basel). 2022 May 6;14(9):2303. doi: 10.3390/cancers14092303. Cancers (Basel). 2022. PMID: 35565432 Free PMC article.
-
Epigenetic Inheritance From Normal Origin Cells Can Determine the Aggressive Biology of Tumor-Initiating Cells and Tumor Heterogeneity.Cancer Control. 2022 Jan-Dec;29:10732748221078160. doi: 10.1177/10732748221078160. Cancer Control. 2022. PMID: 35213254 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous